SCHEMBL7595256

SCHEMBL7595256

COC(=O)OC1(N)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9033761 0.98 NPSR1 (0.30)
SCHEMBL10788939 0.91 NPSR1 (0.38)
Hydrochloric Acid SCHEMBL2234352 0.83 CYP3A4 (0.33)
SCHEMBL6592094 0.83 POLB (0.33)
SCHEMBL5771856 0.83 POLB (0.33)
SCHEMBL3823014 0.82 EPHX2 (0.33)
Hydrochloric Acid SCHEMBL5756872 0.82 POLB (0.32)
Hydrochloric Acid SCHEMBL16774908 0.80
SCHEMBL6684387 0.79 TSHR (0.37)
SCHEMBL3824566 0.78 MMP1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0533832-B1 TREATMENT OF MOOD DISORDERS WITH FUNCTIONAL ANTAGONISTS OF THE GLYCINE/NMDA RECEPTOR COMPLEX US SECRETARY UNITED STATES DEP (US) 2002-11-20 EP claimed